The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gadoterate Meglumine Market Research Report 2025
Synopsis
The global Gadoterate Meglumine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadoterate Meglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadoterate Meglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadoterate Meglumine include Guerbet Group, GE, Bayer, Sanochemia, T2Pharma, b.e.imaging GmbH and Hengrui Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadoterate Meglumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadoterate Meglumine.
Report Scope
The Gadoterate Meglumine market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadoterate Meglumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadoterate Meglumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guerbet Group
GE
Bayer
Sanochemia
T2Pharma
b.e.imaging GmbH
Hengrui Medicine
Segment by Type
1.8845Gm/5Ml
3.769Gm/10Ml
5.6535Gm/15Ml
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadoterate Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadoterate Meglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Gadoterate Meglumine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadoterate Meglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadoterate Meglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadoterate Meglumine include Guerbet Group, GE, Bayer, Sanochemia, T2Pharma, b.e.imaging GmbH and Hengrui Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadoterate Meglumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadoterate Meglumine.
Report Scope
The Gadoterate Meglumine market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadoterate Meglumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadoterate Meglumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guerbet Group
GE
Bayer
Sanochemia
T2Pharma
b.e.imaging GmbH
Hengrui Medicine
Segment by Type
1.8845Gm/5Ml
3.769Gm/10Ml
5.6535Gm/15Ml
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadoterate Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadoterate Meglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gadoterate Meglumine Market Overview
1.1 Product Overview and Scope of Gadoterate Meglumine
1.2 Gadoterate Meglumine Segment by Type
1.2.1 Global Gadoterate Meglumine Market Value Comparison by Type (2024-2030)
1.2.2 1.8845Gm/5Ml
1.2.3 3.769Gm/10Ml
1.2.4 5.6535Gm/15Ml
1.2.5 Others
1.3 Gadoterate Meglumine Segment by Application
1.3.1 Global Gadoterate Meglumine Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Gadoterate Meglumine Market Size Estimates and Forecasts
1.4.1 Global Gadoterate Meglumine Revenue 2019-2030
1.4.2 Global Gadoterate Meglumine Sales 2019-2030
1.4.3 Global Gadoterate Meglumine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gadoterate Meglumine Market Competition by Manufacturers
2.1 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gadoterate Meglumine Average Price by Manufacturers (2019-2024)
2.4 Global Gadoterate Meglumine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gadoterate Meglumine, Product Type & Application
2.7 Gadoterate Meglumine Market Competitive Situation and Trends
2.7.1 Gadoterate Meglumine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gadoterate Meglumine Players Market Share by Revenue
2.7.3 Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gadoterate Meglumine Retrospective Market Scenario by Region
3.1 Global Gadoterate Meglumine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gadoterate Meglumine Global Gadoterate Meglumine Sales by Region: 2019-2030
3.2.1 Global Gadoterate Meglumine Sales by Region: 2019-2024
3.2.2 Global Gadoterate Meglumine Sales by Region: 2025-2030
3.3 Global Gadoterate Meglumine Global Gadoterate Meglumine Revenue by Region: 2019-2030
3.3.1 Global Gadoterate Meglumine Revenue by Region: 2019-2024
3.3.2 Global Gadoterate Meglumine Revenue by Region: 2025-2030
3.4 North America Gadoterate Meglumine Market Facts & Figures by Country
3.4.1 North America Gadoterate Meglumine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gadoterate Meglumine Sales by Country (2019-2030)
3.4.3 North America Gadoterate Meglumine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gadoterate Meglumine Market Facts & Figures by Country
3.5.1 Europe Gadoterate Meglumine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gadoterate Meglumine Sales by Country (2019-2030)
3.5.3 Europe Gadoterate Meglumine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gadoterate Meglumine Market Facts & Figures by Country
3.6.1 Asia Pacific Gadoterate Meglumine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gadoterate Meglumine Sales by Country (2019-2030)
3.6.3 Asia Pacific Gadoterate Meglumine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gadoterate Meglumine Market Facts & Figures by Country
3.7.1 Latin America Gadoterate Meglumine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gadoterate Meglumine Sales by Country (2019-2030)
3.7.3 Latin America Gadoterate Meglumine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gadoterate Meglumine Market Facts & Figures by Country
3.8.1 Middle East and Africa Gadoterate Meglumine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gadoterate Meglumine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gadoterate Meglumine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gadoterate Meglumine Sales by Type (2019-2030)
4.1.1 Global Gadoterate Meglumine Sales by Type (2019-2024)
4.1.2 Global Gadoterate Meglumine Sales by Type (2025-2030)
4.1.3 Global Gadoterate Meglumine Sales Market Share by Type (2019-2030)
4.2 Global Gadoterate Meglumine Revenue by Type (2019-2030)
4.2.1 Global Gadoterate Meglumine Revenue by Type (2019-2024)
4.2.2 Global Gadoterate Meglumine Revenue by Type (2025-2030)
4.2.3 Global Gadoterate Meglumine Revenue Market Share by Type (2019-2030)
4.3 Global Gadoterate Meglumine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gadoterate Meglumine Sales by Application (2019-2030)
5.1.1 Global Gadoterate Meglumine Sales by Application (2019-2024)
5.1.2 Global Gadoterate Meglumine Sales by Application (2025-2030)
5.1.3 Global Gadoterate Meglumine Sales Market Share by Application (2019-2030)
5.2 Global Gadoterate Meglumine Revenue by Application (2019-2030)
5.2.1 Global Gadoterate Meglumine Revenue by Application (2019-2024)
5.2.2 Global Gadoterate Meglumine Revenue by Application (2025-2030)
5.2.3 Global Gadoterate Meglumine Revenue Market Share by Application (2019-2030)
5.3 Global Gadoterate Meglumine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Guerbet Group
6.1.1 Guerbet Group Corporation Information
6.1.2 Guerbet Group Description and Business Overview
6.1.3 Guerbet Group Gadoterate Meglumine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Guerbet Group Gadoterate Meglumine Product Portfolio
6.1.5 Guerbet Group Recent Developments/Updates
6.2 GE
6.2.1 GE Corporation Information
6.2.2 GE Description and Business Overview
6.2.3 GE Gadoterate Meglumine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GE Gadoterate Meglumine Product Portfolio
6.2.5 GE Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gadoterate Meglumine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Gadoterate Meglumine Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Sanochemia
6.4.1 Sanochemia Corporation Information
6.4.2 Sanochemia Description and Business Overview
6.4.3 Sanochemia Gadoterate Meglumine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanochemia Gadoterate Meglumine Product Portfolio
6.4.5 Sanochemia Recent Developments/Updates
6.5 T2Pharma
6.5.1 T2Pharma Corporation Information
6.5.2 T2Pharma Description and Business Overview
6.5.3 T2Pharma Gadoterate Meglumine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 T2Pharma Gadoterate Meglumine Product Portfolio
6.5.5 T2Pharma Recent Developments/Updates
6.6 b.e.imaging GmbH
6.6.1 b.e.imaging GmbH Corporation Information
6.6.2 b.e.imaging GmbH Description and Business Overview
6.6.3 b.e.imaging GmbH Gadoterate Meglumine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 b.e.imaging GmbH Gadoterate Meglumine Product Portfolio
6.6.5 b.e.imaging GmbH Recent Developments/Updates
6.7 Hengrui Medicine
6.6.1 Hengrui Medicine Corporation Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
6.7.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gadoterate Meglumine Industry Chain Analysis
7.2 Gadoterate Meglumine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gadoterate Meglumine Production Mode & Process
7.4 Gadoterate Meglumine Sales and Marketing
7.4.1 Gadoterate Meglumine Sales Channels
7.4.2 Gadoterate Meglumine Distributors
7.5 Gadoterate Meglumine Customers
8 Gadoterate Meglumine Market Dynamics
8.1 Gadoterate Meglumine Industry Trends
8.2 Gadoterate Meglumine Market Drivers
8.3 Gadoterate Meglumine Market Challenges
8.4 Gadoterate Meglumine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gadoterate Meglumine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gadoterate Meglumine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gadoterate Meglumine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gadoterate Meglumine Sales (K L) of Key Manufacturers (2019-2024)
Table 5. Global Gadoterate Meglumine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gadoterate Meglumine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gadoterate Meglumine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gadoterate Meglumine Average Price (US$/L) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gadoterate Meglumine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gadoterate Meglumine, Product Type & Application
Table 12. Global Key Manufacturers of Gadoterate Meglumine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gadoterate Meglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadoterate Meglumine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gadoterate Meglumine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gadoterate Meglumine Sales by Region (2019-2024) & (K L)
Table 18. Global Gadoterate Meglumine Sales Market Share by Region (2019-2024)
Table 19. Global Gadoterate Meglumine Sales by Region (2025-2030) & (K L)
Table 20. Global Gadoterate Meglumine Sales Market Share by Region (2025-2030)
Table 21. Global Gadoterate Meglumine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gadoterate Meglumine Revenue Market Share by Region (2019-2024)
Table 23. Global Gadoterate Meglumine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gadoterate Meglumine Revenue Market Share by Region (2025-2030)
Table 25. North America Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gadoterate Meglumine Sales by Country (2019-2024) & (K L)
Table 27. North America Gadoterate Meglumine Sales by Country (2025-2030) & (K L)
Table 28. North America Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gadoterate Meglumine Sales by Country (2019-2024) & (K L)
Table 32. Europe Gadoterate Meglumine Sales by Country (2025-2030) & (K L)
Table 33. Europe Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gadoterate Meglumine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gadoterate Meglumine Sales by Region (2019-2024) & (K L)
Table 37. Asia Pacific Gadoterate Meglumine Sales by Region (2025-2030) & (K L)
Table 38. Asia Pacific Gadoterate Meglumine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gadoterate Meglumine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gadoterate Meglumine Sales by Country (2019-2024) & (K L)
Table 42. Latin America Gadoterate Meglumine Sales by Country (2025-2030) & (K L)
Table 43. Latin America Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gadoterate Meglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gadoterate Meglumine Sales by Country (2019-2024) & (K L)
Table 47. Middle East & Africa Gadoterate Meglumine Sales by Country (2025-2030) & (K L)
Table 48. Middle East & Africa Gadoterate Meglumine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gadoterate Meglumine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gadoterate Meglumine Sales (K L) by Type (2019-2024)
Table 51. Global Gadoterate Meglumine Sales (K L) by Type (2025-2030)
Table 52. Global Gadoterate Meglumine Sales Market Share by Type (2019-2024)
Table 53. Global Gadoterate Meglumine Sales Market Share by Type (2025-2030)
Table 54. Global Gadoterate Meglumine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gadoterate Meglumine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gadoterate Meglumine Revenue Market Share by Type (2019-2024)
Table 57. Global Gadoterate Meglumine Revenue Market Share by Type (2025-2030)
Table 58. Global Gadoterate Meglumine Price (US$/L) by Type (2019-2024)
Table 59. Global Gadoterate Meglumine Price (US$/L) by Type (2025-2030)
Table 60. Global Gadoterate Meglumine Sales (K L) by Application (2019-2024)
Table 61. Global Gadoterate Meglumine Sales (K L) by Application (2025-2030)
Table 62. Global Gadoterate Meglumine Sales Market Share by Application (2019-2024)
Table 63. Global Gadoterate Meglumine Sales Market Share by Application (2025-2030)
Table 64. Global Gadoterate Meglumine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gadoterate Meglumine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gadoterate Meglumine Revenue Market Share by Application (2019-2024)
Table 67. Global Gadoterate Meglumine Revenue Market Share by Application (2025-2030)
Table 68. Global Gadoterate Meglumine Price (US$/L) by Application (2019-2024)
Table 69. Global Gadoterate Meglumine Price (US$/L) by Application (2025-2030)
Table 70. Guerbet Group Corporation Information
Table 71. Guerbet Group Description and Business Overview
Table 72. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 73. Guerbet Group Gadoterate Meglumine Product
Table 74. Guerbet Group Recent Developments/Updates
Table 75. GE Corporation Information
Table 76. GE Description and Business Overview
Table 77. GE Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 78. GE Gadoterate Meglumine Product
Table 79. GE Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 83. Bayer Gadoterate Meglumine Product
Table 84. Bayer Recent Developments/Updates
Table 85. Sanochemia Corporation Information
Table 86. Sanochemia Description and Business Overview
Table 87. Sanochemia Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 88. Sanochemia Gadoterate Meglumine Product
Table 89. Sanochemia Recent Developments/Updates
Table 90. T2Pharma Corporation Information
Table 91. T2Pharma Description and Business Overview
Table 92. T2Pharma Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 93. T2Pharma Gadoterate Meglumine Product
Table 94. T2Pharma Recent Developments/Updates
Table 95. b.e.imaging GmbH Corporation Information
Table 96. b.e.imaging GmbH Description and Business Overview
Table 97. b.e.imaging GmbH Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 98. b.e.imaging GmbH Gadoterate Meglumine Product
Table 99. b.e.imaging GmbH Recent Developments/Updates
Table 100. Hengrui Medicine Corporation Information
Table 101. Hengrui Medicine Description and Business Overview
Table 102. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 103. Hengrui Medicine Gadoterate Meglumine Product
Table 104. Hengrui Medicine Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Gadoterate Meglumine Distributors List
Table 108. Gadoterate Meglumine Customers List
Table 109. Gadoterate Meglumine Market Trends
Table 110. Gadoterate Meglumine Market Drivers
Table 111. Gadoterate Meglumine Market Challenges
Table 112. Gadoterate Meglumine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gadoterate Meglumine
Figure 2. Global Gadoterate Meglumine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gadoterate Meglumine Market Share by Type in 2023 & 2030
Figure 4. 1.8845Gm/5Ml Product Picture
Figure 5. 3.769Gm/10Ml Product Picture
Figure 6. 5.6535Gm/15Ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gadoterate Meglumine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Gadoterate Meglumine Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Global Gadoterate Meglumine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gadoterate Meglumine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Gadoterate Meglumine Sales (2019-2030) & (K L)
Figure 15. Global Gadoterate Meglumine Average Price (US$/L) & (2019-2030)
Figure 16. Gadoterate Meglumine Report Years Considered
Figure 17. Gadoterate Meglumine Sales Share by Manufacturers in 2023
Figure 18. Global Gadoterate Meglumine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Gadoterate Meglumine Players: Market Share by Revenue in 2023
Figure 20. Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Gadoterate Meglumine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Gadoterate Meglumine Sales Market Share by Country (2019-2030)
Figure 23. North America Gadoterate Meglumine Revenue Market Share by Country (2019-2030)
Figure 24. United States Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Gadoterate Meglumine Sales Market Share by Country (2019-2030)
Figure 27. Europe Gadoterate Meglumine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Gadoterate Meglumine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Gadoterate Meglumine Revenue Market Share by Region (2019-2030)
Figure 35. China Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Gadoterate Meglumine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Gadoterate Meglumine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Gadoterate Meglumine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Gadoterate Meglumine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Gadoterate Meglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Gadoterate Meglumine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Gadoterate Meglumine by Type (2019-2030)
Figure 56. Global Gadoterate Meglumine Price (US$/L) by Type (2019-2030)
Figure 57. Global Sales Market Share of Gadoterate Meglumine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Gadoterate Meglumine by Application (2019-2030)
Figure 59. Global Gadoterate Meglumine Price (US$/L) by Application (2019-2030)
Figure 60. Gadoterate Meglumine Value Chain
Figure 61. Gadoterate Meglumine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
